Home/Saccharo/Margaret Kim, MBA

MK

Margaret Kim, MBA

CFO

Therapeutic Areas

Saccharo Pipeline

Drug	Indication	Phase
SAC-253	Oncology (broad potential)	Preclinical

Leadership Team at Saccharo

Sherry (Sheryl) Martin-Moe, PhD

CEO, President, Founder

CSO, Inventor, Co-Founder

Susan Hershenson, PhD

View full Saccharo profile